This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wagner, J. D. Articles by Adams, M. R. Search for Related Content PubMed PubMed Citation Articles by Wagner, J. D. Articles by Adams, M. R.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1473-1480.)
© 1996 American Heart Association, Inc.

Articles

Esterified Estrogens With and Without Methyltestosterone Decrease Arterial LDL Metabolism in Cynomolgus Monkeys

Janice D. Wagner; Li Zhang; J. Koudy Williams; Thomas C. Register; Dennis M. Ackerman; Brinda Wiita; Thomas B. Clarkson; Michael R. Adams

the Comparative Medicine Clinical Research Center (J.D.W., L.Z., J.K.W., T.C.R., T.B.C., M.R.A.), Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC, and Solvay Pharmaceuticals, Inc (D.M.A., B.W.), Marietta, Ga.

Correspondence to Janice D. Wagner, DVM, PhD, Department of Comparative Medicine, Bowman Gray School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157-1040. E-mail j wagner@cpm.bgsm.edu.

Although both epidemiological and experimental evidence suggests that estrogen replacement therapy reduces the risk of coronary heart disease, the mechanisms for this beneficial effect are largely unknown. Furthermore, the addition of progestins or androgens to estrogen replacement therapy is of concern. The objective of this study was to examine the effects of esterified estrogens alone or in combination with an androgen on arterial LDL metabolism and early atherogenesis in ovariectomized female cynomolgus monkeys. Arterial LDL metabolism was assessed by using dual-labeled LDL that was injected 24 hours before necropsy. Arterial LDL degradation was reduced by 64% to 84% and cholesteryl ester content was decreased by 50% in the thoracic aorta in both treatment groups compared with controls. In addition, aortic lipid peroxidation products, as assessed by thiobarbituric acid reaction, were significantly lower in animals treated with esterified estrogens, with a similar trend for combined estrogen-androgen treatment. Both treatments also reduced plasma concentrations of apoB-containing lipoproteins, reduced LDL particle size, and increased total-body LDL catabolism. The combination of decreased arterial LDL metabolism, decreased arterial lipid peroxidation, and improved plasma lipoprotein metabolism may explain some of the protective effects of estrogens on coronary heart disease and indicate that beneficial actions extend to a combination of estrogen and androgen.

Key Words: estrogen • androgen • women's health • cardiovascular disease • menopause

This article has been cited by other articles:

				T. S Mikkola and T. B Clarkson Estrogen replacement therapy, atherosclerosis, and vascular function Cardiovasc Res, February 15, 2002; 53(3): 605 - 619. [Abstract] [Full Text] [PDF]

				S. Vega-Lopez, R. L. Vidal-Quintanar, and M. L. Fernandez Sex and hormonal status influence plasma lipid responses to psyllium Am. J. Clinical Nutrition, October 1, 2001; 74(4): 435 - 441. [Abstract] [Full Text] [PDF]

				R. K. Dubey and E. K. Jackson Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms Am J Physiol Renal Physiol, March 1, 2001; 280(3): F365 - F388. [Abstract] [Full Text] [PDF]

				M. Seed, R. H Sands, M. McLaren, G. Kirk, and D. Darko The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women Fam. Pract., December 1, 2000; 17(6): 497 - 507. [Abstract] [Full Text] [PDF]

				B. A. Walsh, A. E. Mullick, C. E. Banka, and J. C. Rutledge 17{beta}-Estradiol acts separately on the LDL particle and artery wall to reduce LDL accumulation J. Lipid Res., January 1, 2000; 41(1): 134 - 141. [Abstract] [Full Text]

				X. Zhu, B. Bonet, H. Gillenwater, and R. H. Knopp Opposing Effects of Estrogen and Progestins on LDL Oxidation and Vascular Wall Cytotoxicity: Implications for Atherogenesis Experimental Biology and Medicine, December 1, 1999; 222(3): 214 - 221. [Abstract] [Full Text]

				K. A. Greaves, J. S. Parks, J. K. Williams, and J. D. Wagner Intact Dietary Soy Protein, but Not Adding an Isoflavone-Rich Soy Extract to Casein, Improves Plasma Lipids in Ovariectomized Cynomolgus Monkeys J. Nutr., August 1, 1999; 129(8): 1585 - 1592. [Abstract] [Full Text]

				S. Davis Androgen Replacement in Women: A Commentary J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1886 - 1891. [Abstract] [Full Text]

				G. Gardner, C. L. Banka, K. A. Roberts, A. E. Mullick, and J. C. Rutledge Modified LDL–Mediated Increases in Endothelial Layer Permeability Are Attenuated With 17ß-Estradiol Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 854 - 861. [Abstract] [Full Text] [PDF]

				D. C. Schwenke, J. D. Wagner, and M. R. Adams In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones J. Lipid Res., February 1, 1999; 40(2): 235 - 244. [Abstract] [Full Text]

				J. D. Wagner, M. J. Thomas, J. K. Williams, L. Zhang, K. A. Greaves, and W. T. Cefalu Insulin Sensitivity and Cardiovascular Risk Factors in Ovariectomized Monkeys with Estradiol Alone or Combined with Nomegestrol Acetate J. Clin. Endocrinol. Metab., March 1, 1998; 83(3): 896 - 901. [Abstract] [Full Text]